Anti-STRADA antibody (50-100) {Biotin}

Référence NB-22-59986-100

Conditionnement : 100ug

Marque : Neo Biotech

Demander plus d'informations

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

General Info

Host: Rabbit
Applications: ELISA/IHC/IP/WB
Reactivity: Human/Monkey
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-STRADA (50-100) is suitable for use in ELISA, Immunohistochemistry, Immunoprecipitation and Western Blot research applications.
Clonality: Polyclonal
Conjugation: Biotin
Isotype: IgG
Purification: Affinity Purified
Concentration: 0.64-0.72 µg/µl
Dilution Range: WB: 1:500
DB: 1:10, 000
ELISA: 1:10, 000
IP: 1:150
IHC: 1:50-1:150
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.

Information

Gene Symbol: STRADA
Gene ID: 92335
Uniprot ID: STRAA_HUMAN
Immunogen Region: 50-100
Immunogen: Synthetic peptide taken within amino acid region 50-100 on human STE-20 related kinase adapter protein alpha.

Description

Function Pseudokinase which, in complex with CAB39/MO25 (CAB39/MO25alpha or CAB39L/MO25beta), binds to and activates STK11/LKB1. Adopts a closed conformation typical of active protein kinases and binds STK11/LKB1 as a pseudosubstrate, promoting conformational change of STK11/LKB1 in an active conformation.
Protein Name Ste20-Related Kinase Adapter Protein Alpha
Strad Alpha
Ste20-Related Adapter Protein
Serologically Defined Breast Cancer Antigen Ny-Br-96
Database Links Reactome: R-HSA-380972
Cellular Localisation Nucleus
Cytoplasm
Alternative Antibody Names Anti-Ste20-Related Kinase Adapter Protein Alpha antibody
Anti-Strad Alpha antibody
Anti-Ste20-Related Adapter Protein antibody
Anti-Serologically Defined Breast Cancer Antigen Ny-Br-96 antibody
Anti-STRADA antibody
Anti-LYK5 antibody
Anti-STRAD antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance